Heterologous saRNA Prime, DNA Dual-Antigen Boost SARS-CoV-2 Vaccination Elicits Robust Cellular Immunogenicity and Cross-Variant Neutralizing Antibodies

por Rice, Adrian, Verma, Mohit, Voigt, Emily, Battisti, Peter, Beaver, Sam, Reed, Sierra, Dinkins, Kyle, Mody, Shivani, Zakin, Lise, Tanaka, Shiho, Morimoto, Brett, Olson, C. Anders, Gabitzsch, Elizabeth, Safrit, Jeffrey T., Spilman, Patricia, Casper, Corey, Soon-Shiong, Patrick
Publicado 2022

Intranasal plus subcutaneous prime vaccination with a dual antigen COVID-19 vaccine elicits T-cell and antibody responses in mice

por Rice, Adrian, Verma, Mohit, Shin, Annie, Zakin, Lise, Sieling, Peter, Tanaka, Shiho, Balint, Joseph, Dinkins, Kyle, Adisetiyo, Helty, Morimoto, Brett, Higashide, Wendy, Anders Olson, C., Mody, Shivani, Spilman, Patricia, Gabitzsch, Elizabeth, Safrit, Jeffrey T., Rabizadeh, Shahrooz, Niazi, Kayvan, Soon-Shiong, Patrick
Publicado 2021

Dual-Antigen COVID-19 Vaccine Subcutaneous Prime Delivery With Oral Boosts Protects NHP Against SARS-CoV-2 Challenge

por Gabitzsch, Elizabeth, Safrit, Jeffrey T., Verma, Mohit, Rice, Adrian, Sieling, Peter, Zakin, Lise, Shin, Annie, Morimoto, Brett, Adisetiyo, Helty, Wong, Raymond, Bezawada, Ashish, Dinkins, Kyle, Balint, Joseph, Peykov, Victor, Garban, Hermes, Liu, Philip, Bacon, Andrew, Bone, Pete, Drew, Jeff, Sanford, Daniel C., Spilman, Patricia, Sender, Lennie, Rabizadeh, Shahrooz, Niazi, Kayvan, Soon-Shiong, Patrick
Publicado 2021